Related Experiment Videos
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine
The Journal of Pharmacy and Pharmacology
|March 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers.
Journal of psychopharmacology (Oxford, England)·2011
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding.
Nuclear medicine and biology·1996
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
European journal of pharmacology·1992
Introductory comments: a brief history of the development of paroxetine.
International clinical psychopharmacology·1992
In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.
Life sciences·1992
Borneol exerts an enhanced anti-tumor effect on triple-negative breast cancer by targeting PTGS2 to reinforce gemcitabine-induced DNA damage.
The Journal of pharmacy and pharmacology·2026
Intervention effects and underlying mechanisms of bioactive components from Citrus species on type 2 diabetes and fatty liver diseases: a mechanistic review.
The Journal of pharmacy and pharmacology·2026
A marker-standardized Melastoma malabathricum leaf extract-poly(lactic-co-glycolic acid) nanocurcumin hydrogel improves repair in splinted diabetic wounds in mice.
The Journal of pharmacy and pharmacology·2026
Nanoliposomal curcumin protects against D-galactose-induced hepatic aging by targeting oxidative stress, mitochondrial dysfunction, and inflammatory signaling.
The Journal of pharmacy and pharmacology·2026
Cinnamon plays a key role in the anti-obesity action of Hachimijiogan by ameliorating leptin resistance in the hypothalamus.
The Journal of pharmacy and pharmacology·2026
Evaluating seltorexant as a treatment option for major depressive disorder.
Expert review of neurotherapeutics·2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.
International journal of obesity (2005)·2026